These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3280537)

  • 1. Administration of pharmaceutical preparations by extra-label routes: special considerations and potential pitfalls.
    Jenkins WL; Friedlander LG
    J Am Vet Med Assoc; 1988 Jan; 192(2):256-61. PubMed ID: 3280537
    [No Abstract]   [Full Text] [Related]  

  • 2. Extra-label drug use: with rights come responsibilities.
    Cleland JL
    J Am Vet Med Assoc; 1996 Sep; 209(5):897-8. PubMed ID: 8790533
    [No Abstract]   [Full Text] [Related]  

  • 3. Extra-label drug use--veterinary practitioner views: companion animals.
    Cleland JL
    J Am Vet Med Assoc; 1993 May; 202(10):1642-4;discussion 1654-58. PubMed ID: 8514572
    [No Abstract]   [Full Text] [Related]  

  • 4. Privileges and responsibilities relating to extra-label drug use.
    Upson DW
    J Am Vet Med Assoc; 1988 Jan; 192(2):242-6. PubMed ID: 3350755
    [No Abstract]   [Full Text] [Related]  

  • 5. Refining procedures for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/Universities Federation for Animal Welfare.
    Morton DB; Jennings M; Buckwell A; Ewbank R; Godfrey C; Holgate B; Inglis I; James R; Page C; Sharman I; Verschoyle R; Westall L; Wilson AB;
    Lab Anim; 2001 Jan; 35(1):1-41. PubMed ID: 11201285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibiotics and drugs in veterinary medicine. 1].
    Pilloud M
    Schweiz Arch Tierheilkd; 1984 Nov; 126(11):571-87. PubMed ID: 6393331
    [No Abstract]   [Full Text] [Related]  

  • 7. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of unlicensed and off-label medicines in the neonate.
    Conroy S; McIntyre J
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):115-22. PubMed ID: 15701577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in pharmacokinetics in the aged and their practical consequences].
    Höffler D
    Z Gerontol; 1981; 14(5):382-7. PubMed ID: 7303810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viewpoint: drug eluting stents.
    Gershlick AH
    Circulation; 2006 Feb; 113(6):f23-4. PubMed ID: 16479633
    [No Abstract]   [Full Text] [Related]  

  • 11. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of human-label drugs in veterinary medicine.
    Reid JS
    J Am Vet Med Assoc; 1988 Jan; 192(2):247-9. PubMed ID: 3350756
    [No Abstract]   [Full Text] [Related]  

  • 13. Symposium on the Case for Responsible Extra-Label Drug Use. Presented at the 124th annual AVMA meeting. July 19-23, 1987, Chicago, Ill. Proceedings.
    J Am Vet Med Assoc; 1988 Jan; 192(2):241-70. PubMed ID: 3350754
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific information regarding withholding times associated with extra-label drug uses: selective condemnation.
    Mercer HD
    J Am Vet Med Assoc; 1988 Jan; 192(2):265-7. PubMed ID: 3350757
    [No Abstract]   [Full Text] [Related]  

  • 15. [A survey on the use of antibiotics in veterinary medicine (author's transl)].
    Boisseau J
    Toxicol Eur Res; 1982 Mar; 4(2):77-82. PubMed ID: 7112568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterinary pharmaceutics in Australia.
    Chapman C
    Br Vet J; 1989; 145(2):97-8. PubMed ID: 2713642
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety considerations in development of new animal drugs.
    Fogleman RW
    J Am Vet Med Assoc; 1972 Dec; 161(11):1381-4. PubMed ID: 4638516
    [No Abstract]   [Full Text] [Related]  

  • 18. Responsible extra-label use of drugs.
    Reece TR
    J Am Vet Med Assoc; 1996 Nov; 209(9):1545-6. PubMed ID: 8899013
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label.
    Menon-Andersen D; Yu B; Madabushi R; Bhattaram V; Hao W; Uppoor RS; Mehta M; Lesko L; Temple R; Stockbridge N; Laughren T; Gobburu JV
    Clin Pharmacol Ther; 2011 Sep; 90(3):471-4. PubMed ID: 21796114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Subconjunctival administration of drugs].
    Nuritdinov VA
    Vestn Oftalmol; 1979; (4):44-7. PubMed ID: 505722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.